Anthony G. Brazil

    Partner
    Los Angeles
    Direct: 213.417.5120
    Main: 213.891.9100

    Practice Focus:

    • Main Biography
    • Pharmaceuticals, Medical Devices & Biologics
    • Products Liability

    The primary focus of Mr. Brazil’s practice is the representation of pharmaceutical, medical device, biotech and nutritional supplement companies in a broad array of product liability claims as well as other complex and multidistrict litigation matters. He is currently acting as National Coordinating Counsel for the maker of a dermal filler, the worldwide leader in the design and development of robotic technology utilized in minimally invasive surgery, and a manufacturer of modular hip prosthesis and for a quinine manufacturer. In addition, he provides risk management and counseling services for pharmaceutical, medical device and biotech companies. Mr. Brazil has served as California counsel for corporations in the Fen-Phen, pedicle screw, VIOXX, Fosamax, Quinine and Thimerosal vaccine litigation. In addition, he has acted as national, regional and local counsel in other nationwide pharmaceutical, medical device, and mass tort litigation. Representation includes compounds for the treatment of arthritis, diabetes, latex, gloves, mental illness, endocrine disorders, pain and infection and devices ranging from surgical robots to infusion pumps, pacemakers, defibrillators, lasers, angioplasty products, patient monitors, blood gas products, prosthetic devices and radiation equipment.

    Education

    • J.D., Loyola Law School, 1978
    • B.S., University of Southern California, 1975, cum laude

    Court Admissions

    • United States Court of Appeals for the Ninth Circuit
    • United States District Court for the Central, Eastern, Northern and Southern Districts of California
    • Admitted Pro Hac Vice in State and Federal Courts throughout the United States

    Bar Admissions

    • California, 1978

    Professional Memberships and Activities

    • Steering Committee of the Drug and Device Committee of Defense Research Institute
    • Drug Information Association
    • International Association of Defense Counsel
    • Past Board Member, Association of Southern California Defense Counsel
    • Adjunct Professor, Massachusetts General Hospital, Institute of Health Professions, 1999-2002
    • Arbitrator and Settlement Referee for Los Angeles Superior Court

    Distinctions

    • 2010 Southern California Super Lawyer
    • 2009 Southern California Super Lawyer
    • 2008 Southern California Super Lawyer
    • 2005 Southern California Super Lawyer
    • 2004 Southern California Super Lawyer 

    Speeches and Publications

    •  Co-Defendants in Drug & Medical Device Litigation - Powerful Allies/Dangerous Enemies, New Jersey, September 15, 2009
    •  Failure To Warn Claims, DRI's Drug & Medical Device Litigation Primer, Chicago, IL, September 23, 2008
    •  TV, Radio, Pring and the Internet: Identifying Business Parameters for Device Manufacturers' New Foray into DTC Marketing, American Conference Institute, Chicago, IL, June 18, 2008
    •  Legal and Regulatory Issues for the Life Sciences Industry, Whitehouse Station, New Jersey, April 2, 2008
    •  Loss and Litigation Trends in the Life Sciences Industry, Advanced Life Sciences Producer – Underwriter Forum, Phoenix, Arizona, October 17, 2007
    •  Anatomy of a Life Science Claim, Life Sciences Claims Seminar, Warren, New Jersey, September 25, 2007
    •  It Can't Happen to Us, 3rd Annual Life Sciences Forum, Cambridge, Massachusetts, June 7, 2007
    •  Depositions of Industry CEO’s – The Jerry Springer Show, Survivor or Dancing with the Stars?, Medtech Insights In 3 West, Irvine, California, February 27, 2007
    •  Defenses in Drug and Medical Device Litigation: A Primer for Young Lawyers, DRI, Chicago, Illinois, October 18, 2005
    •  The Life Sciences Litigation Minefield, Life Sciences Producer/Underwriter Forum, San Jose, California, September 20-21,2005
    •  Product Liability Law for Regulatory Affairs Professionals, Guest lecturer, San Diego State University, May, 2005
    •  Current Trends and Hot Topics in Drug and Device Litigation, DRI Drug & Medical Device Seminar, San Francisco, California, May 7, 2004
    •  Off-Label Use, Innovative Defense Strategies in Drug and Medical Device Litigation, LexisNexis Conference, Scottsdale, Arizona, March 23, 2004
    •  PhRMA Guidelines Change the Rules on the Interactions Between the Pharmaceutical Industry and Healthcare Professionals, IADC Drug, Device and Biotech Newsletter, September, 2002
    •  Clinical Trials and Tribulations: How to Reduce Your Risk of Litigation, BIO 2002 Annual Convention, Toronto, Ontario, Canada, June 12, 2002
    •  Legal Implications of FDA Filings – What You Say Will Be Used Against You, RAPS 2001 Annual Meeting, Baltimore, MD, November 6, 2001
    •  The Admissibility of Medical Device Reports in Civil Litigation, Medical Device & Diagnostic Industry Magazine, January, 2001
    •  The Admissibility of Medical Device Reports in Civil Litigation, Regulatory Affairs Professional Society (RAPS) Annual Meeting, Washington, D.C., October 3, 2000
    •  New Restatement’s Definition of Design Defect: Status of Adoption by the Courts, IADC Drug, Device and Biotech Newsletter, April, 2000
    •  Product Risk Management for the Enterprising Biotech Firm, BIO ’99, Seattle, WA, May, 1999
    •  An Introduction to Litigation, Massachusetts General Hospital, Institute of Health Professions, Boston, MA, March, 1999
    •  Failure to Warn Issues for Young Marketing and Sales Employees, Medmarc Series Conference, Newport Beach, CA, October, 1998
    •  Clinical Trials from a Product Liability Perspective, Massachusetts General Hospital, Institute of Health Professions, Boston, MA, June, 1998
    •  Civil Litigation Arising from Product Labeling, BIO ’98 International, New York, NY, June, 1998
    •  Medical Devices/Pharmaceuticals: The Claim and Litigation Process, Health Pro Advanced Technology Seminar, San Diego, CA, October, 1997
    •  Training and Monitoring a Pharmaceutical and/or Medical Device Sales Force, Food, Drug, Cosmetic and Medical Device Law Digest, September, 1997  
    • Training and Monitoring a Pharmaceutical and/or Medical Device Sales Force, Drug Information Association Semi-Annual Meeting, Philadelphia, PA, March, 1997